Source: Eur Respir J 2006; 28: 16-23
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Diel R., Ernst M., Doscher G., Visuri-Karbe L., Greinert U., Niemann S., Nienhaus A., Lange C.. Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Eur Respir J 2006; 28: 16-23

Member's Comments

No comment yet.

Related content which might interest you: Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 Negative effect of ferritin levels on T-SPOT.TB, an enzyme-linked immunospot based interferon-gamma release assay using Mycobacterium tuberculosis specific antigens, in the smear-positive active pulmonary tuberculosis. Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018 Comparison between the antigen-specific interferon-gamma assay and the tuberculin skin testing for the detection of tuberculosis infection among BCG vaccinated schoolers at risk for tuberculosis exposure Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOTTM.TB assay Source: Eur Respir J 2007; 29: 605-607 Year: 2007 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection Source: Eur Respir J 2006; 28: 24-30 Year: 2006 Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1238-1239 Year: 2011 Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection Source: Eur Respir J 2010; 35: 619-626 Year: 2010 LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009 Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-γ assay Source: Eur Respir J 2007; 29: 1212-1216 Year: 2007 Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection Source: Eur Respir J 2010; 36: 135-142 Year: 2010 Contribution of a whole blood IFN-gamma release assay for diagnosis of M. tuberculosis infection in BCG-vaccinated children Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients Source: Eur Respir J 2006; 28: 31-34 Year: 2006 Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis Source: Eur Respir J 2007; 30: 722-728 Year: 2007 Time interval to conversion of interferon-? release assay after exposure to tuberculosis Source: Eur Respir J 2011; 37: 1447-1452 Year: 2011 Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1237-1238 Year: 2011 Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Relationship between the whole blood interferon-gamma responses and the risk of active tuberculosis Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection Year: 2006 Clinical evaluation of anti-glycopeptidelipid core immunoglobulin A antibody assay for serodiagnosis of pulmonary Mycobacterium avium-intracellulare complex (MAC) disease Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005 Effect of prophylaxis on responses for ESAT-6/CFP-10 in whole blood IFN-g test Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis Year: 2005